Detailed answers about ALMAFSAL MEDICAL COMPANY LTD, including incorporation, status, business activity, and accounts information.
When was ALMAFSAL MEDICAL COMPANY LTD founded?
ALMAFSAL MEDICAL COMPANY LTD was officially incorporated on 14 October 2024 and is registered under company number 16015690. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is ALMAFSAL MEDICAL COMPANY LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of ALMAFSAL MEDICAL COMPANY LTD?
ALMAFSAL MEDICAL COMPANY LTD's current status is Active - Proposal to Strike off. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does ALMAFSAL MEDICAL COMPANY LTD do?
ALMAFSAL MEDICAL COMPANY LTD operates in the following sectors: 46460 - Wholesale of pharmaceutical goods, 46690 - Wholesale of other machinery and equipment, 46900 - Non-specialised wholesale trade, 47749 - Retail sale of medical and orthopaedic goods in specialised stores (not incl. hearing aids) n.e.c.. These SIC codes provide insight into the company's business activities and industry focus.
What is ALMAFSAL MEDICAL COMPANY LTD's registered address?
The registered office address of ALMAFSAL MEDICAL COMPANY LTD is PO Box 4385, 16015690 - COMPANIES HOUSE DEFAULT ADDRESS, CARDIFF, CF14 8LH. This is the official address filed with Companies House for legal and statutory correspondence.
Is ALMAFSAL MEDICAL COMPANY LTD financially stable?
Financial accounts for ALMAFSAL MEDICAL COMPANY LTD are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.